The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell and Gene Therapy CDMO Services Market Research Report 2025

Global Cell and Gene Therapy CDMO Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1949422

No of Pages : 101

Ask Your Query
Synopsis
Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) services involve companies providing specialized expertise and infrastructure for the development, manufacturing, and commercialization of cell and gene therapy products on behalf of biopharmaceutical companies. These services encompass a range of activities, including process development, analytical testing, regulatory support, and manufacturing at various scales, from preclinical to commercial production. CDMOs play a critical role in accelerating the translation of cell and gene therapies from research to clinical application by offering tailored solutions to meet the unique requirements of each therapy, ultimately helping to bring innovative treatments to patients more efficiently and effectively.
The global Cell and Gene Therapy CDMO Services market was valued at US$ 5598 million in 2023 and is anticipated to reach US$ 42510 million by 2030, witnessing a CAGR of 32.9% during the forecast period 2024-2030.
Due to complex technical mechanisms, high-threshold process development and large-scale production, strict regulatory requirements, and limited industrialization experience, CGT products are more dependent on CDMOs than traditional pharmaceuticals. Its outsourcing penetration rate exceeds 65%, far exceeding 35% of traditional biologics.
Considering that the production of viral vectors as the core involves very complex processes, is extremely difficult, and has a long preparation cycle, it is expected that the outsourcing rate of CGT will remain high in the future.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy CDMO Services.
The Cell and Gene Therapy CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell and Gene Therapy CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OxfordBioMedica
BrammerBio
CELLfor CURE
OBiO Technology
GenScript
Esco
Nikon
FUJIFILM
Pharmaron
Porton
Medicilon
JOINN Laboratories
Sofpromed
eXmoor
OmniaBio
RoslinCT
BioCentriq
PolTREG
Miltenyi Bioindustry
Segment by Type
Autologous Cell Therapy Products
Allogeneic Cell Therapy Products
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Autologous Cell Therapy Products
1.2.3 Allogeneic Cell Therapy Products
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy CDMO Services Market Perspective (2019-2030)
2.2 Global Cell and Gene Therapy CDMO Services Growth Trends by Region
2.2.1 Global Cell and Gene Therapy CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell and Gene Therapy CDMO Services Historic Market Size by Region (2019-2024)
2.2.3 Cell and Gene Therapy CDMO Services Forecasted Market Size by Region (2025-2030)
2.3 Cell and Gene Therapy CDMO Services Market Dynamics
2.3.1 Cell and Gene Therapy CDMO Services Industry Trends
2.3.2 Cell and Gene Therapy CDMO Services Market Drivers
2.3.3 Cell and Gene Therapy CDMO Services Market Challenges
2.3.4 Cell and Gene Therapy CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy CDMO Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy CDMO Services Players by Revenue (2019-2024)
3.1.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy CDMO Services Revenue
3.4 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy CDMO Services Revenue in 2023
3.5 Global Key Players of Cell and Gene Therapy CDMO Services Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application
3.7 Global Key Players of Cell and Gene Therapy CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy CDMO Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy CDMO Services Historic Market Size by Type (2019-2024)
4.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2025-2030)
5 Cell and Gene Therapy CDMO Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy CDMO Services Historic Market Size by Application (2019-2024)
5.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell and Gene Therapy CDMO Services Market Size (2019-2030)
6.2 North America Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
6.4 North America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy CDMO Services Market Size (2019-2030)
7.2 Europe Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
7.4 Europe Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy CDMO Services Market Size (2019-2030)
9.2 Latin America Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
9.4 Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Cell and Gene Therapy CDMO Services Introduction
11.1.4 Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Cell and Gene Therapy CDMO Services Introduction
11.2.4 Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Introduction
11.3.4 Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.3.5 Thermo Fisher Recent Development
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Details
11.4.2 WuXi AppTec Business Overview
11.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Introduction
11.4.4 WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.4.5 WuXi AppTec Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Cell and Gene Therapy CDMO Services Introduction
11.5.4 Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.5.5 Charles River Recent Development
11.6 OxfordBioMedica
11.6.1 OxfordBioMedica Company Details
11.6.2 OxfordBioMedica Business Overview
11.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Introduction
11.6.4 OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.6.5 OxfordBioMedica Recent Development
11.7 BrammerBio
11.7.1 BrammerBio Company Details
11.7.2 BrammerBio Business Overview
11.7.3 BrammerBio Cell and Gene Therapy CDMO Services Introduction
11.7.4 BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.7.5 BrammerBio Recent Development
11.8 CELLfor CURE
11.8.1 CELLfor CURE Company Details
11.8.2 CELLfor CURE Business Overview
11.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Introduction
11.8.4 CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.8.5 CELLfor CURE Recent Development
11.9 OBiO Technology
11.9.1 OBiO Technology Company Details
11.9.2 OBiO Technology Business Overview
11.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Introduction
11.9.4 OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.9.5 OBiO Technology Recent Development
11.10 GenScript
11.10.1 GenScript Company Details
11.10.2 GenScript Business Overview
11.10.3 GenScript Cell and Gene Therapy CDMO Services Introduction
11.10.4 GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.10.5 GenScript Recent Development
11.11 Esco
11.11.1 Esco Company Details
11.11.2 Esco Business Overview
11.11.3 Esco Cell and Gene Therapy CDMO Services Introduction
11.11.4 Esco Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.11.5 Esco Recent Development
11.12 Nikon
11.12.1 Nikon Company Details
11.12.2 Nikon Business Overview
11.12.3 Nikon Cell and Gene Therapy CDMO Services Introduction
11.12.4 Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.12.5 Nikon Recent Development
11.13 FUJIFILM
11.13.1 FUJIFILM Company Details
11.13.2 FUJIFILM Business Overview
11.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Introduction
11.13.4 FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.13.5 FUJIFILM Recent Development
11.14 Pharmaron
11.14.1 Pharmaron Company Details
11.14.2 Pharmaron Business Overview
11.14.3 Pharmaron Cell and Gene Therapy CDMO Services Introduction
11.14.4 Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.14.5 Pharmaron Recent Development
11.15 Porton
11.15.1 Porton Company Details
11.15.2 Porton Business Overview
11.15.3 Porton Cell and Gene Therapy CDMO Services Introduction
11.15.4 Porton Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.15.5 Porton Recent Development
11.16 Medicilon
11.16.1 Medicilon Company Details
11.16.2 Medicilon Business Overview
11.16.3 Medicilon Cell and Gene Therapy CDMO Services Introduction
11.16.4 Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.16.5 Medicilon Recent Development
11.17 JOINN Laboratories
11.17.1 JOINN Laboratories Company Details
11.17.2 JOINN Laboratories Business Overview
11.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Introduction
11.17.4 JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.17.5 JOINN Laboratories Recent Development
11.18 Sofpromed
11.18.1 Sofpromed Company Details
11.18.2 Sofpromed Business Overview
11.18.3 Sofpromed Cell and Gene Therapy CDMO Services Introduction
11.18.4 Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.18.5 Sofpromed Recent Development
11.19 eXmoor
11.19.1 eXmoor Company Details
11.19.2 eXmoor Business Overview
11.19.3 eXmoor Cell and Gene Therapy CDMO Services Introduction
11.19.4 eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.19.5 eXmoor Recent Development
11.20 OmniaBio
11.20.1 OmniaBio Company Details
11.20.2 OmniaBio Business Overview
11.20.3 OmniaBio Cell and Gene Therapy CDMO Services Introduction
11.20.4 OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.20.5 OmniaBio Recent Development
11.21 RoslinCT
11.21.1 RoslinCT Company Details
11.21.2 RoslinCT Business Overview
11.21.3 RoslinCT Cell and Gene Therapy CDMO Services Introduction
11.21.4 RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.21.5 RoslinCT Recent Development
11.22 BioCentriq
11.22.1 BioCentriq Company Details
11.22.2 BioCentriq Business Overview
11.22.3 BioCentriq Cell and Gene Therapy CDMO Services Introduction
11.22.4 BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.22.5 BioCentriq Recent Development
11.23 PolTREG
11.23.1 PolTREG Company Details
11.23.2 PolTREG Business Overview
11.23.3 PolTREG Cell and Gene Therapy CDMO Services Introduction
11.23.4 PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.23.5 PolTREG Recent Development
11.24 Miltenyi Bioindustry
11.24.1 Miltenyi Bioindustry Company Details
11.24.2 Miltenyi Bioindustry Business Overview
11.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Introduction
11.24.4 Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
11.24.5 Miltenyi Bioindustry Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Autologous Cell Therapy Products
Table 3. Key Players of Allogeneic Cell Therapy Products
Table 4. Global Cell and Gene Therapy CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Cell and Gene Therapy CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cell and Gene Therapy CDMO Services Market Share by Region (2019-2024)
Table 8. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cell and Gene Therapy CDMO Services Market Share by Region (2025-2030)
Table 10. Cell and Gene Therapy CDMO Services Market Trends
Table 11. Cell and Gene Therapy CDMO Services Market Drivers
Table 12. Cell and Gene Therapy CDMO Services Market Challenges
Table 13. Cell and Gene Therapy CDMO Services Market Restraints
Table 14. Global Cell and Gene Therapy CDMO Services Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cell and Gene Therapy CDMO Services Market Share by Players (2019-2024)
Table 16. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2023)
Table 17. Ranking of Global Top Cell and Gene Therapy CDMO Services Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy CDMO Services Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Cell and Gene Therapy CDMO Services, Headquarters and Area Served
Table 20. Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application
Table 21. Global Key Players of Cell and Gene Therapy CDMO Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2019-2024)
Table 25. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2025-2030)
Table 27. Global Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2019-2024)
Table 29. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2025-2030)
Table 31. North America Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Catalent Company Details
Table 47. Catalent Business Overview
Table 48. Catalent Cell and Gene Therapy CDMO Services Product
Table 49. Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 50. Catalent Recent Development
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Cell and Gene Therapy CDMO Services Product
Table 54. Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Thermo Fisher Company Details
Table 57. Thermo Fisher Business Overview
Table 58. Thermo Fisher Cell and Gene Therapy CDMO Services Product
Table 59. Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Recent Development
Table 61. WuXi AppTec Company Details
Table 62. WuXi AppTec Business Overview
Table 63. WuXi AppTec Cell and Gene Therapy CDMO Services Product
Table 64. WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 65. WuXi AppTec Recent Development
Table 66. Charles River Company Details
Table 67. Charles River Business Overview
Table 68. Charles River Cell and Gene Therapy CDMO Services Product
Table 69. Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 70. Charles River Recent Development
Table 71. OxfordBioMedica Company Details
Table 72. OxfordBioMedica Business Overview
Table 73. OxfordBioMedica Cell and Gene Therapy CDMO Services Product
Table 74. OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 75. OxfordBioMedica Recent Development
Table 76. BrammerBio Company Details
Table 77. BrammerBio Business Overview
Table 78. BrammerBio Cell and Gene Therapy CDMO Services Product
Table 79. BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 80. BrammerBio Recent Development
Table 81. CELLfor CURE Company Details
Table 82. CELLfor CURE Business Overview
Table 83. CELLfor CURE Cell and Gene Therapy CDMO Services Product
Table 84. CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 85. CELLfor CURE Recent Development
Table 86. OBiO Technology Company Details
Table 87. OBiO Technology Business Overview
Table 88. OBiO Technology Cell and Gene Therapy CDMO Services Product
Table 89. OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 90. OBiO Technology Recent Development
Table 91. GenScript Company Details
Table 92. GenScript Business Overview
Table 93. GenScript Cell and Gene Therapy CDMO Services Product
Table 94. GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 95. GenScript Recent Development
Table 96. Esco Company Details
Table 97. Esco Business Overview
Table 98. Esco Cell and Gene Therapy CDMO Services Product
Table 99. Esco Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 100. Esco Recent Development
Table 101. Nikon Company Details
Table 102. Nikon Business Overview
Table 103. Nikon Cell and Gene Therapy CDMO Services Product
Table 104. Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 105. Nikon Recent Development
Table 106. FUJIFILM Company Details
Table 107. FUJIFILM Business Overview
Table 108. FUJIFILM Cell and Gene Therapy CDMO Services Product
Table 109. FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 110. FUJIFILM Recent Development
Table 111. Pharmaron Company Details
Table 112. Pharmaron Business Overview
Table 113. Pharmaron Cell and Gene Therapy CDMO Services Product
Table 114. Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 115. Pharmaron Recent Development
Table 116. Porton Company Details
Table 117. Porton Business Overview
Table 118. Porton Cell and Gene Therapy CDMO Services Product
Table 119. Porton Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 120. Porton Recent Development
Table 121. Medicilon Company Details
Table 122. Medicilon Business Overview
Table 123. Medicilon Cell and Gene Therapy CDMO Services Product
Table 124. Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 125. Medicilon Recent Development
Table 126. JOINN Laboratories Company Details
Table 127. JOINN Laboratories Business Overview
Table 128. JOINN Laboratories Cell and Gene Therapy CDMO Services Product
Table 129. JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 130. JOINN Laboratories Recent Development
Table 131. Sofpromed Company Details
Table 132. Sofpromed Business Overview
Table 133. Sofpromed Cell and Gene Therapy CDMO Services Product
Table 134. Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 135. Sofpromed Recent Development
Table 136. eXmoor Company Details
Table 137. eXmoor Business Overview
Table 138. eXmoor Cell and Gene Therapy CDMO Services Product
Table 139. eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 140. eXmoor Recent Development
Table 141. OmniaBio Company Details
Table 142. OmniaBio Business Overview
Table 143. OmniaBio Cell and Gene Therapy CDMO Services Product
Table 144. OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 145. OmniaBio Recent Development
Table 146. RoslinCT Company Details
Table 147. RoslinCT Business Overview
Table 148. RoslinCT Cell and Gene Therapy CDMO Services Product
Table 149. RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 150. RoslinCT Recent Development
Table 151. BioCentriq Company Details
Table 152. BioCentriq Business Overview
Table 153. BioCentriq Cell and Gene Therapy CDMO Services Product
Table 154. BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 155. BioCentriq Recent Development
Table 156. PolTREG Company Details
Table 157. PolTREG Business Overview
Table 158. PolTREG Cell and Gene Therapy CDMO Services Product
Table 159. PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 160. PolTREG Recent Development
Table 161. Miltenyi Bioindustry Company Details
Table 162. Miltenyi Bioindustry Business Overview
Table 163. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product
Table 164. Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)
Table 165. Miltenyi Bioindustry Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
Table 169. Authors List of This Report


List of Figures
Figure 1. Cell and Gene Therapy CDMO Services Picture
Figure 2. Global Cell and Gene Therapy CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cell and Gene Therapy CDMO Services Market Share by Type: 2023 VS 2030
Figure 4. Autologous Cell Therapy Products Features
Figure 5. Allogeneic Cell Therapy Products Features
Figure 6. Global Cell and Gene Therapy CDMO Services Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Cell and Gene Therapy CDMO Services Market Share by Application: 2023 VS 2030
Figure 8. SMBs Case Studies
Figure 9. Large Companies Case Studies
Figure 10. Cell and Gene Therapy CDMO Services Report Years Considered
Figure 11. Global Cell and Gene Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cell and Gene Therapy CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cell and Gene Therapy CDMO Services Market Share by Region: 2023 VS 2030
Figure 14. Global Cell and Gene Therapy CDMO Services Market Share by Players in 2023
Figure 15. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CDMO Services Revenue in 2023
Figure 17. North America Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
Figure 19. United States Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
Figure 23. Germany Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Region (2019-2030)
Figure 31. China Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
Figure 39. Mexico Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)
Figure 43. Turkey Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. UAE Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Catalent Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 47. Lonza Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 48. Thermo Fisher Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 49. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 50. Charles River Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 51. OxfordBioMedica Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 52. BrammerBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 53. CELLfor CURE Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 54. OBiO Technology Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 55. GenScript Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 56. Esco Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 57. Nikon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 58. FUJIFILM Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 59. Pharmaron Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 60. Porton Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 61. Medicilon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 62. JOINN Laboratories Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 63. Sofpromed Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 64. eXmoor Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 65. OmniaBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 66. RoslinCT Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 67. BioCentriq Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 68. PolTREG Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 69. Miltenyi Bioindustry Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock